Subsequently, other studies confirmed our initial findings of SRSF3 overexpression in breast cancer 113, colon cancer 114, or cervical cancer 115, colorectal cancer 67, 116, and other types of cancers including oral squamous cell carcinoma 117, ovarian cancer 118, 119, and glioblastoma 80, 82. This evidence concerns the gene SRSF3 and ovarian carcinoma.